Logo image of ADN1.DE

ADESSO SE (ADN1.DE) Stock Fundamental Analysis

Europe - FRA:ADN1 - DE000A0Z23Q5 - Common Stock

91.1 EUR
+0.6 (+0.66%)
Last: 11/4/2025, 5:27:54 PM
Fundamental Rating

5

Taking everything into account, ADN1 scores 5 out of 10 in our fundamental rating. ADN1 was compared to 70 industry peers in the IT Services industry. Both the profitability and the financial health of ADN1 get a neutral evaluation. Nothing too spectacular is happening here. ADN1 is not priced too expensively while it is growing strongly. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

ADN1 had positive earnings in the past year.
ADN1 had a positive operating cash flow in the past year.
In the past 5 years ADN1 has always been profitable.
ADN1 had a positive operating cash flow in each of the past 5 years.
ADN1.DE Yearly Net Income VS EBIT VS OCF VS FCFADN1.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

ADN1 has a Return On Assets of 2.34%. This is in the lower half of the industry: ADN1 underperforms 61.43% of its industry peers.
ADN1 has a Return On Equity (11.09%) which is comparable to the rest of the industry.
Looking at the Return On Invested Capital, with a value of 5.34%, ADN1 is doing worse than 61.43% of the companies in the same industry.
ADN1 had an Average Return On Invested Capital over the past 3 years of 3.16%. This is significantly below the industry average of 21.24%.
The last Return On Invested Capital (5.34%) for ADN1 is above the 3 year average (3.16%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.34%
ROE 11.09%
ROIC 5.34%
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
ADN1.DE Yearly ROA, ROE, ROICADN1.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

1.3 Margins

With a Profit Margin value of 0.96%, ADN1 is not doing good in the industry: 64.29% of the companies in the same industry are doing better.
ADN1's Profit Margin has declined in the last couple of years.
ADN1's Operating Margin of 3.04% is on the low side compared to the rest of the industry. ADN1 is outperformed by 64.29% of its industry peers.
In the last couple of years the Operating Margin of ADN1 has declined.
The Gross Margin of ADN1 (85.66%) is better than 75.71% of its industry peers.
In the last couple of years the Gross Margin of ADN1 has remained more or less at the same level.
Industry RankSector Rank
OM 3.04%
PM (TTM) 0.96%
GM 85.66%
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
ADN1.DE Yearly Profit, Operating, Gross MarginsADN1.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ADN1 is destroying value.
The number of shares outstanding for ADN1 has been reduced compared to 1 year ago.
ADN1 has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, ADN1 has an improved debt to assets ratio.
ADN1.DE Yearly Shares OutstandingADN1.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M
ADN1.DE Yearly Total Debt VS Total AssetsADN1.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

An Altman-Z score of 3.57 indicates that ADN1 is not in any danger for bankruptcy at the moment.
ADN1 has a better Altman-Z score (3.57) than 75.71% of its industry peers.
ADN1 has a debt to FCF ratio of 4.22. This is a neutral value as ADN1 would need 4.22 years to pay back of all of its debts.
ADN1 has a Debt to FCF ratio of 4.22. This is comparable to the rest of the industry: ADN1 outperforms 50.00% of its industry peers.
ADN1 has a Debt/Equity ratio of 0.89. This is a neutral value indicating ADN1 is somewhat dependend on debt financing.
The Debt to Equity ratio of ADN1 (0.89) is worse than 60.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 4.22
Altman-Z 3.57
ROIC/WACC0.95
WACC5.61%
ADN1.DE Yearly LT Debt VS Equity VS FCFADN1.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M

2.3 Liquidity

ADN1 has a Current Ratio of 1.26. This is a normal value and indicates that ADN1 is financially healthy and should not expect problems in meeting its short term obligations.
ADN1 has a Current ratio of 1.26. This is comparable to the rest of the industry: ADN1 outperforms 57.14% of its industry peers.
A Quick Ratio of 1.26 indicates that ADN1 should not have too much problems paying its short term obligations.
The Quick ratio of ADN1 (1.26) is better than 62.86% of its industry peers.
Industry RankSector Rank
Current Ratio 1.26
Quick Ratio 1.26
ADN1.DE Yearly Current Assets VS Current LiabilitesADN1.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 1204.39% over the past year.
ADN1 shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.02% yearly.
Looking at the last year, ADN1 shows a quite strong growth in Revenue. The Revenue has grown by 12.81% in the last year.
ADN1 shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.60% yearly.
EPS 1Y (TTM)1204.39%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%42.38%
Revenue 1Y (TTM)12.81%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%12.43%

3.2 Future

The Earnings Per Share is expected to grow by 39.76% on average over the next years. This is a very strong growth
ADN1 is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 10.48% yearly.
EPS Next Y104.81%
EPS Next 2Y79.87%
EPS Next 3Y64.74%
EPS Next 5Y39.76%
Revenue Next Year10.46%
Revenue Next 2Y10.44%
Revenue Next 3Y10.29%
Revenue Next 5Y10.48%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
ADN1.DE Yearly Revenue VS EstimatesADN1.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
ADN1.DE Yearly EPS VS EstimatesADN1.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 5 10

5

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 30.07, the valuation of ADN1 can be described as expensive.
The rest of the industry has a similar Price/Earnings ratio as ADN1.
When comparing the Price/Earnings ratio of ADN1 to the average of the S&P500 Index (26.03), we can say ADN1 is valued inline with the index average.
The Price/Forward Earnings ratio is 15.44, which indicates a correct valuation of ADN1.
The rest of the industry has a similar Price/Forward Earnings ratio as ADN1.
When comparing the Price/Forward Earnings ratio of ADN1 to the average of the S&P500 Index (22.27), we can say ADN1 is valued slightly cheaper.
Industry RankSector Rank
PE 30.07
Fwd PE 15.44
ADN1.DE Price Earnings VS Forward Price EarningsADN1.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ADN1 is valued a bit cheaper than 75.71% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of ADN1 indicates a somewhat cheap valuation: ADN1 is cheaper than 64.29% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 11.05
EV/EBITDA 5.76
ADN1.DE Per share dataADN1.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 100 200 300

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ADN1's earnings are expected to grow with 64.74% in the coming years.
PEG (NY)0.29
PEG (5Y)N/A
EPS Next 2Y79.87%
EPS Next 3Y64.74%

4

5. Dividend

5.1 Amount

ADN1 has a yearly dividend return of 0.81%, which is pretty low.
ADN1's Dividend Yield is comparable with the industry average which is at 3.86.
Compared to an average S&P500 Dividend Yield of 2.38, ADN1's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.81%

5.2 History

On average, the dividend of ADN1 grows each year by 15.65%, which is quite nice.
Dividend Growth(5Y)15.65%
Div Incr Years5
Div Non Decr Years6
ADN1.DE Yearly Dividends per shareADN1.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

ADN1 pays out 33.51% of its income as dividend. This is a sustainable payout ratio.
The dividend of ADN1 is growing, but earnings are growing more, so the dividend growth is sustainable.
DP33.51%
EPS Next 2Y79.87%
EPS Next 3Y64.74%
ADN1.DE Yearly Income VS Free CF VS DividendADN1.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M
ADN1.DE Dividend Payout.ADN1.DE Dividend Payout, showing the Payout Ratio.ADN1.DE Dividend Payout.PayoutRetained Earnings

ADESSO SE

FRA:ADN1 (11/4/2025, 5:27:54 PM)

91.1

+0.6 (+0.66%)

Chartmill FA Rating
GICS IndustryGroupSoftware & Services
GICS IndustryIT Services
Earnings (Last)08-14 2025-08-14
Earnings (Next)11-12 2025-11-12
Inst Owners19.2%
Inst Owner ChangeN/A
Ins Owners49.34%
Ins Owner ChangeN/A
Market Cap594.88M
Revenue(TTM)2.06B
Net Income(TTM)19.75M
Analysts81.54
Price Target127.79 (40.27%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.81%
Yearly Dividend0.94
Dividend Growth(5Y)15.65%
DP33.51%
Div Incr Years5
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0.92%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)-7.67%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.41%
Valuation
Industry RankSector Rank
PE 30.07
Fwd PE 15.44
P/S 0.29
P/FCF 11.05
P/OCF 7.04
P/B 3.34
P/tB 16.38
EV/EBITDA 5.76
EPS(TTM)3.03
EY3.33%
EPS(NY)5.9
Fwd EY6.48%
FCF(TTM)8.24
FCFY9.05%
OCF(TTM)12.94
OCFY14.21%
SpS315.32
BVpS27.28
TBVpS5.56
PEG (NY)0.29
PEG (5Y)N/A
Graham Number43.12
Profitability
Industry RankSector Rank
ROA 2.34%
ROE 11.09%
ROCE 12.16%
ROIC 5.34%
ROICexc 5.9%
ROICexgc 8.47%
OM 3.04%
PM (TTM) 0.96%
GM 85.66%
FCFM 2.61%
ROA(3y)1.93%
ROA(5y)3.99%
ROE(3y)6.49%
ROE(5y)13.12%
ROIC(3y)3.16%
ROIC(5y)4.51%
ROICexc(3y)4.06%
ROICexc(5y)6.01%
ROICexgc(3y)6.65%
ROICexgc(5y)10.11%
ROCE(3y)7.2%
ROCE(5y)10.26%
ROICexgc growth 3Y-20.34%
ROICexgc growth 5Y-12.01%
ROICexc growth 3Y-21.84%
ROICexc growth 5Y-11.01%
OM growth 3Y-30%
OM growth 5Y-15.03%
PM growth 3Y-55.28%
PM growth 5Y-30.54%
GM growth 3Y-0.02%
GM growth 5Y-0.7%
F-Score8
Asset Turnover2.44
Health
Industry RankSector Rank
Debt/Equity 0.89
Debt/FCF 4.22
Debt/EBITDA 1.19
Cap/Depr 43.51%
Cap/Sales 1.49%
Interest Coverage 4.84
Cash Conversion 63.53%
Profit Quality 272.63%
Current Ratio 1.26
Quick Ratio 1.26
Altman-Z 3.57
F-Score8
WACC5.61%
ROIC/WACC0.95
Cap/Depr(3y)52.06%
Cap/Depr(5y)49.68%
Cap/Sales(3y)2.64%
Cap/Sales(5y)2.54%
Profit Quality(3y)790.41%
Profit Quality(5y)538.39%
High Growth Momentum
Growth
EPS 1Y (TTM)1204.39%
EPS 3Y-45.14%
EPS 5Y-15.02%
EPS Q2Q%42.38%
EPS Next Y104.81%
EPS Next 2Y79.87%
EPS Next 3Y64.74%
EPS Next 5Y39.76%
Revenue 1Y (TTM)12.81%
Revenue growth 3Y24.12%
Revenue growth 5Y23.6%
Sales Q2Q%12.43%
Revenue Next Year10.46%
Revenue Next 2Y10.44%
Revenue Next 3Y10.29%
Revenue Next 5Y10.48%
EBIT growth 1Y69.72%
EBIT growth 3Y-13.12%
EBIT growth 5Y5.01%
EBIT Next Year305.17%
EBIT Next 3Y80.92%
EBIT Next 5Y43.44%
FCF growth 1Y295.38%
FCF growth 3Y40.19%
FCF growth 5Y49.54%
OCF growth 1Y14594.7%
OCF growth 3Y32.14%
OCF growth 5Y37.69%

ADESSO SE / ADN1.DE FAQ

What is the ChartMill fundamental rating of ADESSO SE (ADN1.DE) stock?

ChartMill assigns a fundamental rating of 5 / 10 to ADN1.DE.


What is the valuation status of ADESSO SE (ADN1.DE) stock?

ChartMill assigns a valuation rating of 5 / 10 to ADESSO SE (ADN1.DE). This can be considered as Fairly Valued.


What is the profitability of ADN1 stock?

ADESSO SE (ADN1.DE) has a profitability rating of 4 / 10.


What is the valuation of ADESSO SE based on its PE and PB ratios?

The Price/Earnings (PE) ratio for ADESSO SE (ADN1.DE) is 30.07 and the Price/Book (PB) ratio is 3.34.


Is the dividend of ADESSO SE sustainable?

The dividend rating of ADESSO SE (ADN1.DE) is 4 / 10 and the dividend payout ratio is 33.51%.